Liquidated · 14 Jul 2023ARYE · NasdaqCIK 1852432Sponsor at IPO: ARYA Sciences Holdings V

ARYA Sciences Acquisition Corp V

$150MTrust raised at IPO

IPO12 Jul 2021
Searching24 months
Deal announced—
Liquidated14 Jul 2023

Tavia Read What stands out, from the filings · snapshot 14

01
Smaller than 82% of 2021’s SPAC IPOs.
$150M raised, against a median of $239M for the 610 SPACs that priced in 2021.
02
The trust was liquidated.
Public shares were redeemed and the SPAC did not complete a merger.

Worked out from checked figures in snapshot 14 · no forecasts or advice

Key terms

Other 2021 SPAC IPOs →

IPO priced: 12 Jul 2021
IPO closed: 15 Jul 2021
Raised: $150M¹
Units sold: 14,950,000²
Trust raised: $150M³
Trust per unit: $10.00⁴
Unit: Shares only⁵
Months to complete: 24⁶
Deadline before extensions: 15 Jul 2023
Over-allotment: Exercised in full

Each unit: “shares only: no units, warrants or rights”

How it compares

ARYA Sciences Acquisition Corp V against the 610 SPACs that priced in 2021.

Raised: $150M; 81% of 2021 SPACs are above it; 2021 median: $239M
Trust per unit: $10.00; 63% of 2021 SPACs match it; 2021 median: $10.00
Months to complete: 24; 56% of 2021 SPACs match it; 2021 median: 24

Trust and redemptions

No extension or merger vote with paid redemptions is on record for this SPAC yet.

Firms named in the prospectus

Bookrunners

Other SPACs from ARYA Sciences

ARYA Sciences’s track record →

ARYA Sciences has brought 4 SPACs to market since 1 January 2019, $598M in all: 3 completed, 1 liquidated. 3 of the 4 that reached an end completed a merger.

No SPAC named ARYA Sciences I is in our data. It either priced before 1 January 2019, came to market under another name (SPACs are listed by their name at IPO), never came to market, or is not yet in an approved snapshot, so this record may understate the sponsor.

SPAC	IPO	Raised	Status	Outcome	Months
ARYA Sciences Acquisition Corp V This SPAC	12 Jul 2021	$150M	Liquidated	Trust liquidated	24
ARYA Sciences Acquisition Corp IV	25 Feb 2021	$150M	Completed	Adagio Medical Holdings, Inc. (ADGM)	41
ARYA Sciences Acquisition Corp IIIIPO before 2021	6 Aug 2020	$150M	Completed	Nautilus Biotechnology, Inc. (NAUT)	10
ARYA Sciences Acquisition Corp IIIPO before 2021	4 Jun 2020	$150M	Completed	Cerevel Therapeutics Holdings, Inc. (CERE)	5

Months: from the IPO to the merger’s closing or the liquidation. SPACs are grouped by sponsor when their names, or their sponsor entities, match once the legal form and series numeral are taken off.

Peers

Other 2021 SPAC IPOs with Goldman Sachs & Co. LLC as bookrunner.

SPAC	IPO	Raised	Unit	Status
FTAC Emerald Acquisition Corp.	15 Dec 2021	$249M	1 sh + ½ warrant	Completed
Sculptor Acquisition Corp I	8 Dec 2021	$230M	1 sh + ½ warrant	Liquidated
Ascendant Digital Acquisition Corp. III	9 Nov 2021	$300M	1 sh + ½ warrant	Liquidated
7 Acquisition Corp	4 Nov 2021	$230M	1 sh + ½ warrant	Liquidated
Rigel Resource Acquisition Corp.	4 Nov 2021	$300M	1 sh + ½ warrant	Liquidated

Sources

PFinal prospectus: 0001140361-21-024269
1Gross proceeds: 0001140361-21-024455The Public Shares were sold at an offering price of $10.00 per Public Share, generating gross proceeds of $149,500,000.
2Units sold: 0001140361-21-024455On July 15, 2021 the Company consummated the IPO of 14,950,000 Class A ordinary shares, $0.0001 par value per share (the “Public Shares”), which includes the exercise in full of the underwriters’ option
3Trust raised: 0001140361-21-025214The net proceeds from the IPO, together with certain of the proceeds from the Private Placement, $149,500,000 in the aggregate (the “Offering Proceeds”), were placed in a trust account
4Trust per unit: 0001140361-21-024269$130 million, or $149.5 million if the underwriters’ over-allotment option is exercised in full ($10.00 per share in either case), will be deposited into a trust account located in the United States
5Unit composition: 0001140361-21-024269Unlike many other initial public offerings of special purpose acquisition companies (“SPAC IPOs”), investors in this offering will not receive warrants that would become exercisable following completion of our initial business combination
6Months to complete: 0001140361-21-024269If we do not consummate an initial business combination within 24 months from the closing of this offering, we will redeem 100% of the public shares for cash, subject to applicable law and certain conditions as described herein.

Each quote is found word for word in the filing it cites. Where a figure here differs from the filing, the filing prevails.

How the figures are compiled

Which IPOs. Every final IPO prospectus (Form 424B4 or 424B1, or a 424B3 when it is the first prospectus filed on an S-1 or F-1 registration within 10 days of it going effective) filed on SEC EDGAR from the history start, by a registrant whose SIC code was 6770 (blank checks) on the filing date. Offerings that are not exchange-listed SPAC IPOs are excluded when the prospectus is read. The window starts on 1 January 2021.
Dated by. The date of the final prospectus.
Raised. Units sold to the public, including over-allotment units, times the unit price, as stated in the SPAC's 8-K reports after the IPO.
Trust. The trust held for public shareholders after the IPO and any over-allotment: trust per unit times public units, as stated in the SPAC's filings. Cash deposited in trust and then moved out as working capital is not counted.
Bookrunners. Firms the prospectus names as book-running managers; where it names none, the firm it names as sole underwriter or representative of the underwriters. Only the prospectus's own wording counts, not later 8-K reports. Each IPO's gross proceeds are split equally among its bookrunners.
Counsel and auditors. Issuer counsel and underwriters' counsel as named in the prospectus's Legal Matters section; the auditor as named in its Experts section. Each is credited with the IPO's full gross proceeds.
Unit structure. What one unit consists of, as the prospectus states it: a share with warrants, with rights, with both, or a share alone (shares-only offerings sell no units). Warrants per unit is the fraction of a warrant in each unit; rights are measured as the fraction of a share they convert into per unit.
Trust per unit. Dollars placed in the trust account for each unit sold to the public, as the prospectus states it.
Time to complete. Months from the IPO closing that the SPAC has to complete its business combination before any extension, as the prospectus states it.
Over-allotment. Whether the underwriters bought all, part or none of the over-allotment option, comparing units sold with the base offering and the option.
Votes. Shareholder votes to extend a SPAC's deadline or to approve its business combination, as reported in its 8-Ks (Item 5.07), for the SPACs in the IPO statistics only: SPACs that priced before the history start are not included, so votes in the first years under-represent the market. Only redemptions actually paid count: votes on a proposal that failed, or an extension that was approved but never took effect, are left out (redemption requests lapse with them), and a merger vote counts only when the deal closed, and only the last merger vote before the closing, since merger redemptions are paid at closing. Liquidation votes are left out too, as every public share is redeemed by definition.
Redemption rate. Public shares redeemed at a vote over public shares outstanding just before it. Shares redeemed are as an 8-K, or failing that the next 10-Q or 10-K, states them. Shares before are as a filing states them, or redeemed plus the shares left after, or carried from the IPO's public shares and earlier votes. The median is the typical vote; the weighted rate divides all shares redeemed by all shares before, the share of public money that left the trusts. A vote counts only when each of these figures is verified or accepted. Votes whose redemption count no filing states, after a search of the SPAC's and the combined company's filings, are counted as not disclosed rather than estimated.
Outcomes. Where each SPAC stands as of the snapshot: completed (business combination closed), liquidated (trust returned and redeemed), deal pending (agreement signed, not closed) or searching (no agreement in force). Grouped by the year the SPAC priced its IPO. Awaiting review means its status is still being checked.
Closings. Completed business combinations by year of closing. The sector is the SEC's industry code (SIC) of the combined company, grouped into broad sectors; months from IPO run from the prospectus date to the closing.
Checking. A SPAC counts only when every required figure is verified (quote found verbatim in the filing and all cross-checks pass) or accepted by a named reviewer.
Coverage. 1,077 of the 1,089 SPAC IPOs read are counted; 12 wait on a figure still under review and 11 filings were excluded as not exchange-listed SPAC IPOs.

Compiled from SEC filings with the assistance of AI · figures as of 3 November 2026

For information only. These figures are compiled from SEC filings with the assistance of AI. Although they are checked against those filings, they may contain errors or omissions and have not been audited; where they differ from the filings, the filings prevail. They are not an offer to sell, a solicitation of an offer to buy, or a recommendation of any security. Information about any SPAC is qualified in its entirety by its filings with the SEC, available at www.sec.gov.

Smaller than 82% of 2021’s SPAC IPOs.

The trust was liquidated.